BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19245171)

  • 21. Increased vascular endothelial growth factor expression, CD3-positive cell infiltration, and oxidative stress in premalignant lesions of the cervix.
    Carrero Y; Callejas D; Alaña F; Silva C; Mindiola R; Mosquera J
    Cancer; 2009 Aug; 115(16):3680-8. PubMed ID: 19479977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response.
    Fahim NM; Shehata IH; Taha SE; Fahmy RA; Elsayed MS
    Egypt J Immunol; 2018 Jan; 25(1):125-134. PubMed ID: 30243004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
    Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV-associated premalignant disease of the cervix.
    Odunsi KO; van Ee CC; Ganesan TS; Shelling AN
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):342-5. PubMed ID: 10985891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.
    Mulvany NJ; Allen DG; Wilson SM
    Pathology; 2008 Jun; 40(4):335-44. PubMed ID: 18446622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia.
    Cooper K; Haffajee Z; Taylor L
    Mod Pathol; 1999 Jun; 12(6):612-7. PubMed ID: 10392638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells.
    Trujillo-Cirilo L; Torres-Corioriles EI; Rangel-Corona R; Corona-Ortega MT; Weiss-Steider B
    Cytokine; 2021 Dec; 148():155592. PubMed ID: 34099345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection.
    Xue J; Wang Y; Chen C; Zhu X; Zhu H; Hu Y
    Cancer Med; 2018 Feb; 7(2):297-306. PubMed ID: 29277958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
    El-Sherif AM; Seth R; Tighe PJ; Jenkins D
    J Pathol; 2000 Dec; 192(4):494-501. PubMed ID: 11113867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
    Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
    Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix.
    Cenci M; Pisani T; French D; Alderisio M; Vecchione A
    Anticancer Res; 2005; 25(3B):2187-92. PubMed ID: 16158962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene.
    Lee S; Kim JH; Kim H; Kang JW; Kim SH; Yang Y; Kim J; Park J; Park S; Hong J; Yoon DY
    Immunology; 2011 Mar; 132(3):410-20. PubMed ID: 21208204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Competing-risks regression models in analysis of biomarkers as predictors of high-risk human papillomavirus (HPV) infection outcomes and incident CIN in the LAMS cohort.
    Syrjänen S; Longhato-Filho A; Sarian LO; Naud P; Derchain S; Rottelli-Martins C; Tatti S; Branca M; Eržen M; Hammes LS; Matos J; Gontijo R; Bragança J; Arlindo FC; Maeda MY; Costa S; Syrjänen K
    Int J Gynecol Pathol; 2013 Jul; 32(4):406-15. PubMed ID: 23722514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the plasma and tissue riboflavin levels with C20orf54 expression in cervical lesions and its relationship to HPV16 infection.
    Aili A; Hasim A; Kelimu A; Guo X; Mamtimin B; Abudula A; Upur H
    PLoS One; 2013; 8(11):e79937. PubMed ID: 24260322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.
    de Gruijl TD; Bontkes HJ; van den Muysenberg AJ; van Oostveen JW; Stukart MJ; Verheijen RH; van der Vange N; Snijders PJ; Meijer CJ; Walboomers JM; Scheper RJ
    Eur J Cancer; 1999 Mar; 35(3):490-7. PubMed ID: 10448305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical localization of cdc6 in squamous and glandular neoplasia of the uterine cervix.
    Bonds L; Baker P; Gup C; Shroyer KR
    Arch Pathol Lab Med; 2002 Oct; 126(10):1164-8. PubMed ID: 12296751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical role of p16INK4a expression in liquid-based cervical cytology: correlation with HPV testing and histologic diagnosis.
    Benevolo M; Vocaturo A; Mottolese M; Mariani L; Vocaturo G; Marandino F; Sperduti I; Rollo F; Antoniani B; Donnorso RP
    Am J Clin Pathol; 2008 Apr; 129(4):606-12. PubMed ID: 18343788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.